FOR LABORATORY RESEARCH ONLY Direct quotations · Minimum 1 box

Aging research

Epitalon in normal and cancer cells: telomere pathways differ

A 2025 cell study distinguished telomerase changes from alternative telomere-lengthening activity.

Preclinical studyPaper year: 2025Epithalon / Epitalon

01 / DESIGN

What was studied?

The researchers examined normal epithelial and fibroblast cells alongside breast-cancer cell lines. They measured telomere length, hTERT-related expression, telomerase activity and alternative lengthening of telomeres, or ALT.

02 / FINDINGS

What did the researchers report?

Normal cells showed telomere extension associated with hTERT and telomerase changes. Cancer cells also showed extension, with ALT activation contributing to the reported pattern. The response depended on the cell context.

03 / LIMITS

How should it be interpreted?

Telomere extension in cancer-cell models is a reason for careful interpretation, not a general anti-aging endorsement. The study did not establish lifespan benefits or clinical safety. Its distinct cell mechanisms should not be collapsed into a single claim that longer telomeres are always beneficial.

Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.

WhatsApp ↗